CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (3.45%)
Oct 15, 2025, 2:23 PM EDT
CBD Life Sciences Market Cap
CBD Life Sciences has a market cap or net worth of $1.88 million as of October 15, 2025. Its market cap has increased by 56.08% in one year.
Market Cap
1.88M
Enterprise Value
1.95M
Revenue
178.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 31, 2012, CBD Life Sciences's market cap has decreased from 36.67M to 1.88M, a decrease of -94.87%. That is a compound annual growth rate of -19.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 14, 2025 | 1.88M | 23.86% |
Dec 31, 2024 | 1.52M | 3,469.86% |
Dec 29, 2023 | 42.51K | 4.42% |
Dec 30, 2022 | 40.71K | -99.50% |
Dec 31, 2021 | 8.14M | 62.45% |
Dec 31, 2020 | 5.01M | 909.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Glass House Brands | 698.88M |
Elite Pharmaceuticals | 663.06M |
Veradigm | 514.01M |
Nika Pharmaceuticals | 495.49M |
Northwest Biotherapeutics | 367.43M |
CytoDyn | 350.21M |
American Oncology Network | 283.44M |
Silence Therapeutics | 275.85M |